18F-Fluciclovine Uptake in a Ureterocele

Research output: Contribution to journalArticlepeer-review

Abstract

A 60-year-old man with prostate adenocarcinoma status post radical prostatectomy and bilateral pelvic lymph node dissection referred for restaging 18F-fluciclovine PET/CT due to rising serum prostate-specific antigen levels (1.1 ng/mL at that time of imaging). PET/CT images were obtained from the proximal thighs to the vertex of the skull approximately 3 to 5 minutes after the IV administration of 347.8 MBq (9.4 mCi) of 18F-fluciclovine. PET/CT imaging demonstrated a focus of abnormally increased 18F-fluciclovine uptake at the right ureterovesical junction. Subsequent MRI of the pelvis revealed that this focus corresponded to a benign ureterocele.

Original languageEnglish (US)
Pages (from-to)E3-E5
JournalClinical nuclear medicine
Volume46
Issue number1
DOIs
StatePublished - 2021

Keywords

  • F-fluciclovine
  • PET/CT
  • false-positive
  • pitfalls
  • ureterocele

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of '<sup>18</sup>F-Fluciclovine Uptake in a Ureterocele'. Together they form a unique fingerprint.

Cite this